Mycodern Spolka Akcyjna Logo

Mycodern Spolka Akcyjna

Producer of functional foods and supplements for manufacturing and distribution.

MCD | WAR

Overview

Corporate Details

ISIN(s):
PLMDNPL00013 (+3 more)
LEI:
25940087YXP4K8ENAO45
Country:
Poland
Address:
GDAŃSK JAŚKOWA DOLINA 132/20, 80-286 GDAŃSK

Description

Mycodern Spolka Akcyjna is a producer of functional foods and innovative dietary supplements. The company's product portfolio includes items such as functional gummies and oils. Its business activities encompass contract manufacturing, wholesale, trading, and retail distribution.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-22 15:26
zal03_FormularzA_-_Flash_Fundacja_Rodzinna.pdf
Polish 77.9 KB
2025-12-22 15:26
zal01_FormularzA_-_J.Wasita.pdf
Polish 75.2 KB
2025-12-22 15:26
zal02_FormularzA_-_M.Pastewska.pdf
Polish 79.5 KB
2025-12-22 15:26
Zawiadomienia akcjonariuszy w trybie art. 69 ustawy o ofercie - Content (PL)
Polish 786 bytes
2025-12-18 14:14
Podpisanie umowy o sprawowanie nadzoru nad przebiegiem postępowania restruktury…
Polish 1.7 KB
2025-12-16 17:01
zal01_FormularzA_1.pdf
Polish 77.8 KB
2025-12-16 17:01
Zawiadomienie akcjonariusza w trybie art. 69 ustawy o ofercie - Content (PL)
Polish 467 bytes
2025-12-16 09:18
zal01_FormularzA.pdf
Polish 79.4 KB
2025-12-16 09:18
Zawiadomienie akcjonariusza w trybie art. 69 ustawy o ofercie - Content (PL)
Polish 436 bytes
2024-04-08 15:20
Korekta raportu ESPI nr 4/2024 - Zakończenie emisji oraz przydział akcji serii …
Polish 2.1 KB
2024-03-29 20:50
Zakończenie emisji oraz przydział akcji serii E - Content (PL)
Polish 1.5 KB
2024-01-23 23:32
Zawarcie ramowej umowy w zakresie wytwarzania i dostawy żelków - Content (PL)
Polish 1.2 KB
2024-01-23 23:29
Dokument Ofertowy - MCD
Polish 388.9 KB
2024-01-23 23:29
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posia…
Polish 1.2 KB
2024-01-23 17:20
Zawarcie umowy o współpracy - Content (PL)
Polish 1.7 KB

Automate Your Workflow. Get a real-time feed of all Mycodern Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Mycodern Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Mycodern Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Develops and manufactures biologic medicines, including biosimilars and novel drugs.
South Korea
007460
Develops drugs for intractable diseases by regulating oxidative stress and CAFs.
South Korea
293780
Aptamer Sciences Inc Logo
Clinical-stage company developing aptamer-based therapeutics for oncology.
South Korea
291650
Aptorum Group Ltd Logo
Clinical-stage biopharma developing therapeutics for oncology and infectious diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Pharmaceutical company developing oral film medicines for CNS and allergic reactions.
United States of America
AQST
Arbutus Biopharma Corp Logo
Clinical-stage biopharma company developing a functional cure for chronic Hepatitis B.
United States of America
ABUS
Arcellx, Inc. Logo
A clinical-stage biotech company developing immunotherapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharmaceutical and nutraceutical products from marine membrane lipids.
Norway
ABS
ArcticZymes Technologies Logo
Develops and manufactures novel recombinant enzymes from Arctic marine organisms.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
A commercial-stage mRNA medicines company focused on rare and infectious diseases.
United States of America
ARCT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.